CymitQuimica logo

CAS 1410880-22-6

:

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
  • Ref: IN-DA001FVN

    1mg
    40.00€
    2mg
    49.00€
    5mg
    55.00€
    10mg
    62.00€
    25mg
    119.00€
    50mg
    160.00€
    100mg
    193.00€
    250mg
    496.00€
  • JNK-IN-8

    CAS:
    JNK-IN-8
    Formula:C29H29N7O2
    Purity:≥98%
    Molecular weight:507.59

    Ref: 54-BUP10090

    2mg
    63.00€
    5mg
    107.00€
    10mg
    185.00€
    25mg
    301.00€
    50mg
    491.00€
    100mg
    712.00€
  • JNK-IN-8

    CAS:
    3-(4-(Dimethylamino)but-2-enamido)-N-(3-methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide
    Formula:C29H29N7O2
    Purity:98%
    Molecular weight:507.59
  • JNK-IN-8

    CAS:
    JNK-IN-8 (JNK Inhibitor XVI) is an irreversible JNK1/2/4 inhibitor (IC50: 4.7/18.7/1 nM).
    Formula:C29H29N7O2
    Purity:99.24% - >99.99%
    Color and Shape:White Solid
    Molecular weight:507.59

    Ref: TM-T2668

    2mg
    44.00€
    5mg
    73.00€
    1mL*10mM (DMSO)
    82.00€
    10mg
    113.00€
    25mg
    197.00€
    50mg
    326.00€
    100mg
    482.00€
    200mg
    685.00€
  • JNK-IN-8

    CAS:
    Purity:98%
    Molecular weight:507.238

    Ref: 10-F980080

    5mg
    36.00€
    10mg
    57.00€
    25mg
    98.00€
    50mg
    162.00€
    100mg
    251.00€
  • JNK Inhibitor XVI

    CAS:
    JNK inhibitor XVI is an inhibitor drug that inhibits the JNK protein kinase, which is a member of the MAPK family. It has been shown to inhibit the growth of breast cancer cells in vitro. JNK inhibitor XVI also inhibits autophagy and reactive oxygen species production in these cells, leading to cell death. This drug may be a potential treatment for colorectal adenocarcinoma and epidermal growth factor receptor (EGFR) -positive cancer.
    Formula:C29H29N7O2
    Purity:Min. 95%
    Molecular weight:507.59 g/mol

    Ref: 3D-KGC88022

    25mg
    1,033.00€
    50mg
    1,355.00€
    100mg
    2,110.00€